| Cervical screening start age | Age 21 (regardless of sexual history) (ACOG Practice Bulletin) |
| Pap smear interval (ages 21–29) | Every 3 years (USPSTF, ACOG) |
| HPV co-test interval (ages 30–65) | Every 5 years (or Pap alone every 3 years) (USPSTF recommendation) |
| Bone density screening start age | Age 65 for average-risk women (USPSTF) |
| STI screening (chlamydia/gonorrhea) | Annually for sexually active women under 25 (CDC, USPSTF) |
| HIV screening | At least once for all adults ages 15–65 (USPSTF) |
What Reproductive Health Screenings Cover
Reproductive health screenings are a specific category within the broader landscape of preventive care. As explained in our guide to preventive screenings, these tests are designed to detect conditions before symptoms emerge — not to diagnose illness in someone already unwell. For women, reproductive screenings span cervical health, breast tissue, sexually transmitted infections (STIs), hormonal function, and bone density in later life.
No single schedule fits every woman. Personal and family medical history, age, sexual activity, and genetic risk factors all influence which screenings a provider recommends and how frequently. The information below reflects general guidance from organizations such as the American College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task Force (USPSTF). Always discuss your individual screening plan with a qualified healthcare provider.
| Cervical screening start age | Age 21 (regardless of sexual history) (ACOG Practice Bulletin) |
| Pap smear interval (ages 21–29) | Every 3 years (USPSTF, ACOG) |
| HPV co-test interval (ages 30–65) | Every 5 years (or Pap alone every 3 years) (USPSTF recommendation) |
| Bone density screening start age | Age 65 for average-risk women (USPSTF) |
| STI screening (chlamydia/gonorrhea) | Annually for sexually active women under 25 (CDC, USPSTF) |
| HIV screening | At least once for all adults ages 15–65 (USPSTF) |
Key Screenings: What They Test and When They're Typically Recommended
Cervical Cancer Screening (Pap Smear and HPV Test)
A Pap smear collects cells from the cervix to look for precancerous changes. An HPV (human papillomavirus) co-test checks for high-risk HPV strains that can lead to cervical cancer if untreated. ACOG generally recommends Pap testing beginning at age 21, with co-testing or HPV-only testing options available from age 25 or 30 depending on provider preference and guidelines. Intervals vary from every 3 to 5 years based on results and testing method.
Breast Cancer Screening (Mammography)
Mammography uses low-dose X-ray imaging to detect tumors or tissue changes in the breast. Screening guidelines differ across organizations regarding the ideal starting age (typically between 40 and 50) and frequency (annually or biennially). Women with a family history or genetic markers such as BRCA1/BRCA2 variants may be advised to start earlier. See our comparison of mammograms versus breast ultrasound for more on how each imaging tool is used.
STI Screenings
Chlamydia and gonorrhea screening is recommended annually for sexually active women under 25 and for older women with elevated risk. HIV screening is recommended at least once for all adults aged 15–65, with more frequent testing for those with ongoing risk factors. Syphilis and hepatitis B/C screenings may also be recommended based on individual circumstances.
Bone Density Screening (DEXA Scan)
Bone density testing is typically recommended for women aged 65 and older, or earlier for postmenopausal women with significant risk factors such as low body weight, smoking history, or long-term corticosteroid use. Our dedicated article on bone density scans explains how results are scored and interpreted.
Hormonal and Fertility-Related Assessments
While not universally scheduled as standard screenings, hormonal panels — including thyroid function, anti-Müllerian hormone (AMH), and follicle-stimulating hormone (FSH) — may be ordered when a provider suspects conditions such as polycystic ovary syndrome (PCOS) or concerns about fertility. These are typically diagnostic rather than routine screening tests.
Pap Smear
A cervical screening test in which cells are gently collected from the cervix and examined under a microscope for precancerous or abnormal changes. It is one of the most effective early-detection tools for cervical cancer.
HPV (Human Papillomavirus)
A common sexually transmitted virus with many strains; certain high-risk strains are linked to cervical, vulvar, and other cancers. HPV co-testing is often combined with Pap smears to improve detection accuracy.
Mammography
A low-dose X-ray imaging technique used to detect abnormal tissue changes or tumors in the breast. It is the standard imaging tool for breast cancer screening in average-risk women.
DEXA Scan
Dual-energy X-ray absorptiometry (DEXA) measures bone mineral density to assess osteoporosis risk. It produces a T-score that compares a person's bone density to that of a healthy young adult reference population.
Anti-Müllerian Hormone (AMH)
A hormone produced by cells in ovarian follicles; blood levels are used as a marker of ovarian reserve, or the approximate quantity of remaining eggs. It is not a routine screening test but may be measured when fertility concerns arise.
Colposcopy
A follow-up diagnostic procedure performed when a Pap or HPV test returns an abnormal result. A clinician uses a lighted magnifying instrument to closely examine the cervix for areas that may need biopsy.
Preparing for and Understanding Your Results
Receiving an abnormal result on a reproductive screening can feel alarming, but most abnormal results require follow-up testing — not immediate treatment. An abnormal Pap result, for example, often reflects a minor cellular change that resolves on its own. Clarifying what any result means is best done with your provider, who can place it in the context of your full health history.
Before any screening appointment, it helps to compile a summary of your menstrual cycle patterns, any current medications or supplements, previous screening results, and any symptoms you've noticed — even ones that seem unrelated. Our guide on talking to your doctor about reproductive health concerns offers practical steps for making those conversations more productive.
For women thinking ahead to family planning, some providers also offer assessments relevant to fertility preservation. These discussions are separate from routine screening but are part of a holistic reproductive health conversation.
A broader view of how reproductive screenings fit into lifetime preventive care is available in a family's roadmap to health screenings at every life stage, which maps recommended tests from adolescence through older adulthood.
This article provides general health information for educational purposes only and is not a substitute for personalized medical advice. Consult a qualified healthcare provider to determine the screening schedule most appropriate for your individual health needs.